Heather Preston Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

Heather Preston is Director of Karuna Therapeutics, Inc.. Currently has a direct ownership of 6,556 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Jun 24, 2021, when has been sold 184 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.56K
0% 3M change
0% 12M change
Total Value Held $0

Heather Preston Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2021
BUY
Other acquisition or disposition
-
184 Added 2.73%
6,556 Common Stock
Mar 08 2021
BUY
Other acquisition or disposition
-
572 Added 8.24%
6,372 Common Stock

Also insider at

FUSN
Fusion Pharmaceuticals Inc. Healthcare
Director
AKUS
Akouos, Inc. Healthcare
Director
ALGS
Aligos Therapeutics, Inc. Healthcare
HP

Heather Preston

Director
Boston, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX